More from Renaissance Capital
Referenced Stocks

Radius Health sets terms for IPO

By Renaissance Capital,  October 22, 2012, 11:40:48 AM EDT

Radius Health, a biotech developing treatments to restore bone loss from osteoporosis, announced terms for its IPO on Friday. The Cambridge, MA-based company plans to raise $62 million by offering 6.5 million shares at a price range of $8.50 to $10.50. At the midpoint of the proposed range, Radius Health would command a fully diluted market value of $308 million. Radius Health, which was founded in 2003, plans to list on the NASDAQ under the symbol RDUS. UBS Investment Bank and Leerink Swann are the joint bookrunners on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: News Headlines, IPOs

Referenced Stocks: RDUS



Latest News Video

Take Control Of Your Wealth
Take Control Of Your Wealth         
How to Avoid Getting Caught Pre-Defection
How to Avoid Getting Caught Pre-Def...
WSJ House of the Week: And the Winner Is…
WSJ House of the Week: And the Winn...
How to Invest When Interest Rates Rise
How to Invest When Interest Rates R...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.




Most Active by Volume:

Company Last Sale Change Net / %
PFE $ 29.40 0.24  0.82%
NOK $ 3.86 0.17  4.61%
S $ 7.32 0.10  1.39%
BAC $ 13.27 0.06  0.45%
GE $ 24.33 0.56  2.36%
MU $ 13.76 0.52  3.93%
SIRI $ 3.40 0.06  1.80%
MNKD $ 6.605 0.94  12.40%